Click to discover the importance of clinical studies for developing new medicines & see some of the clinical trials Boehringer Ingelheim have sponsored.
One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health.
We provide vaccines, diagnostics, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs.
A Boehringer Ingelheim é um parceiro e promotor de produção sustentável de carne de porco e proteína animal, assegurando o bem-estar animal através da prevenção e cuidados de saúde integrados.
Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases
Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs.
Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision.
At Boehringer Ingelheim we're improving treatments for patients suffering from a range of cardiovascular conditions atrial fibrillation, stroke & blood clots.
Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Viver com doenças inflamatórias e fibróticas tem um grande impacto na vida dos doentes, tanto física como emcionalmente. Estes doentes guiam-nos e inspiram-nos a transformar ciencia inovadora em descobertas médicas que mudam a vida.
At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers.
Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans.